Managing Drug Resistance in Hepatitis Treatment: What You Need to Know - Gastroenterology and Hepatology

Share to:

What should be done if liver disease develops drug resistance?


Hello...
Six months ago, my ALT and AST levels were over 500.
The e-antigen was positive with a viral load of 1380.
After taking HepaGam for three months, my ALT and AST levels returned to normal, and the viral load decreased to 1.96.
However, after another three months, the e-antigen remained positive, and the viral load increased to 2.36, which is higher than before.
My doctor mentioned the possibility of drug resistance.
What should I do? I am still young.
The doctor said that if I want to turn negative, I would need to continue treatment for at least another six months.
Is that true? Also, are there any side effects from taking HepaGam? Does it affect the kidneys? I have been on it for seven months and have been paying out of pocket.
Should I stop the medication? Is my life going to be dark from now on? Although my liver function is still okay, I am only 26 years old...
Will I have no hope in the future? I am really worried.
Please help me with answers.
I would be very grateful.

A-Hua, 20~29 year old female. Ask Date: 2005/06/23

Dr. Lin Minghui reply Gastroenterology and Hepatology


Hello, generally, taking Hepatitis B medication (such as Entecavir) for one year can lead to the disappearance of the e-antigen, with a 20% chance of developing e-antibodies.
If e-antibodies are produced, you will need to continue taking the medication for another six months.
The likelihood of developing drug resistance after six months of treatment is relatively low.
There are blood tests available to check for drug-resistant viral strains, but these tests are out-of-pocket expenses.
If your GOT and GPT levels are normal, it is still recommended that you continue taking the medication, as it generally has minimal side effects and does not adversely affect the kidneys.
In Taiwan, there are 3 million carriers of Hepatitis B, and historically, when there were no available treatments, most individuals did not experience severe complications.
It is advised that you avoid alcohol, refrain from taking unprescribed medications, maintain a regular lifestyle, and follow your physician's instructions for regular monitoring.
Try not to worry too much.
This message is on behalf of Dr.
Yuan Hong-Dao from the Internal Medicine department.

Reply Date: 2005/06/23

More Info


Managing drug resistance in hepatitis treatment is a critical concern for patients, especially those dealing with chronic hepatitis B virus (HBV) infections. Your situation reflects a common challenge faced by many individuals undergoing antiviral therapy. Here’s a comprehensive overview of what you need to know about managing drug resistance in hepatitis treatment, along with some specific advice based on your circumstances.


Understanding Drug Resistance
Drug resistance in hepatitis B treatment typically occurs when the virus mutates in response to antiviral medications, rendering them less effective. This can lead to an increase in viral load, as you've experienced, where your HBV DNA levels have risen despite ongoing treatment. The presence of e-antigen (HBeAg) positivity indicates active viral replication, which can complicate treatment.


Monitoring and Testing
Regular monitoring of liver function tests (like GOT and GPT) and HBV DNA levels is crucial. If your liver enzymes are elevated and your viral load is increasing, it’s essential to discuss these results with your healthcare provider. They may recommend additional tests, such as a hepatitis B resistance panel, to determine if the virus has developed resistance to the current medication, in your case, “肝安能” (presumably a brand name for an antiviral).


Treatment Options
If drug resistance is confirmed, your doctor may suggest switching to a different antiviral medication. Tenofovir and entecavir are two potent options that are often used in cases of resistance. These medications have a higher barrier to resistance compared to lamivudine and may be more effective in controlling viral replication.


Duration of Treatment
Regarding the duration of treatment, it is generally recommended that patients continue antiviral therapy for at least six months after achieving viral suppression. However, the exact duration can vary based on individual circumstances, including the presence of liver damage and the specific characteristics of the virus. Your doctor will tailor the treatment plan based on your response to therapy and any side effects you may experience.


Side Effects and Concerns
You mentioned concerns about potential side effects of “肝安能,” particularly regarding kidney function. While most antiviral medications for hepatitis B are generally well-tolerated, they can have side effects. It’s important to have regular kidney function tests (like serum creatinine) to monitor for any adverse effects. If you experience any unusual symptoms, such as changes in urination, swelling, or fatigue, you should report these to your doctor immediately.


Emotional and Psychological Support
It’s understandable to feel overwhelmed and anxious about your health, especially at a young age. Chronic illness can significantly impact mental health, so seeking support from friends, family, or a mental health professional can be beneficial. Joining support groups for individuals with hepatitis can also provide a sense of community and shared experience.


Conclusion
In summary, managing drug resistance in hepatitis treatment requires close collaboration with your healthcare provider. Regular monitoring, potential adjustment of medications, and addressing side effects are key components of effective management. While the journey may seem daunting, many patients successfully manage their condition and lead fulfilling lives. It’s essential to stay informed, maintain open communication with your healthcare team, and seek support when needed. Remember, you are not alone in this journey, and there are effective treatments available to help you manage your hepatitis B infection.

Similar Q&A

Understanding Drug Resistance in Hepatitis B Treatment: Key Insights and Concerns

1. The doctor mentioned there are two methods: one is to add liver function support, or switch to the latest hepatitis B medication (entecavir, brand name: Viread). 2. I would like to ask, since I have been taking medication since 2003 and my HBeAg has always been positive, does...


Dr. Chen Qifeng reply Gastroenterology and Hepatology
Hello: The biggest challenge in the treatment of hepatitis B is drug resistance. So far, Tenofovir and Entecavir are considered to have low resistance rates. In the case of Entecavir, there has been no evidence of drug resistance in the five-year studies conducted to date. Additi...

[Read More] Understanding Drug Resistance in Hepatitis B Treatment: Key Insights and Concerns


Understanding Hepatitis B: Treatment Resistance and Monitoring

Hello Dr. Lin, I am a carrier of Hepatitis B. I have been on treatment with ETV (entecavir) for three years. In December and June of last year, my viral load was undetectable, but this June, the viral load was measured at 28. However, the E antigen, which is currently positive, h...


Dr. Lin Minghui reply Gastroenterology and Hepatology
1) Hepcludex is used for chronic hepatitis B, and the chance of developing drug resistance is very low. 2) GPT: 49 indicates elevated liver enzymes; besides hepatitis B, other possible causes such as medications, infections, or non-compliance with medication should be considered....

[Read More] Understanding Hepatitis B: Treatment Resistance and Monitoring


Understanding HBV Resistance: A Case Study in Treatment Challenges

My son is 24 years old and studying for his master's degree in America. He is HBe positive and has a negative HBe antigen. He has been on lamivudine since January 2008. On December 29, 2008, his lab results showed AST 31, ALT 46, and HBV-DNA approximately 500 million copies/...


Dr. Chen Shidian reply Gastroenterology and Hepatology
Hello Mr. John: You may first check for HBV drug resistance (out-of-pocket, available only at a few medical centers). If drug resistance is present, you may consider switching medications (though there is a risk of developing resistance again) or, depending on the situation, swit...

[Read More] Understanding HBV Resistance: A Case Study in Treatment Challenges


Navigating Hepatitis C Treatment: Options, Costs, and Lifestyle Considerations

Hello, doctors. I have been suffering from liver disease for a long time. Five years ago, a blood test revealed that I had both hepatitis B and C viruses. A month later, I went to a Christian hospital for further testing, and it confirmed only hepatitis C. Since then, I have been...


Dr. Yang Peizhen reply Gastroenterology and Hepatology
Hello! First of all, it must be emphasized that hepatitis C is transmitted through blood and bodily fluids, and is fundamentally unrelated to diet. Chronic hepatitis C has a high rate of viral mutation, which makes treatment outcomes less than ideal. Currently, the most effective...

[Read More] Navigating Hepatitis C Treatment: Options, Costs, and Lifestyle Considerations


Related FAQ

Hepatitis B Medication

(Gastroenterology and Hepatology)

Hepatitis

(Gastroenterology and Hepatology)

Medications

(Gastroenterology and Hepatology)

Medication And Diet

(Gastroenterology and Hepatology)

Drug Interactions

(Gastroenterology and Hepatology)

Liver Fibrosis

(Gastroenterology and Hepatology)

Total Bilirubin

(Gastroenterology and Hepatology)

Hepatitis B Infection Risk

(Gastroenterology and Hepatology)

Hepatitis C Infection Risk

(Gastroenterology and Hepatology)

Medication Consultation

(Gastroenterology and Hepatology)